EKB-569, a new irreversible epidermal growth factor receptor tyrosine kinase inhibitor, with clinical activity in patients with non-small cell lung cancer with acquired resistance to gefitinib (Q46858893)
Jump to navigation
Jump to search
scientific article published on 20 December 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | EKB-569, a new irreversible epidermal growth factor receptor tyrosine kinase inhibitor, with clinical activity in patients with non-small cell lung cancer with acquired resistance to gefitinib |
scientific article published on 20 December 2005 |
Statements
1 reference
EKB-569, a new irreversible epidermal growth factor receptor tyrosine kinase inhibitor, with clinical activity in patients with non-small cell lung cancer with acquired resistance to gefitinib (English)
1 reference
Naruo Yoshimura
1 reference
Shinzoh Kudoh
1 reference
Tatsuo Kimura
1 reference
Shigeki Mitsuoka
1 reference
Kuniomi Matsuura
1 reference
Kazuto Hirata
1 reference
Kaoru Matsui
1 reference
Shunichi Negoro
1 reference
Kazuhiko Nakagawa
1 reference
Masahiro Fukuoka
1 reference
20 December 2005
1 reference
1 reference
51
1 reference
3
1 reference
363-368
1 reference